Assessment of chemotherapy regimens on radiation pneumonitis in patients with unresectable stage III non-small-cell lung cancer after definitive chemoradiotherapy.

Tadashi SakaguchiKentaro ItoNaoki Furuya Kei MorikawaKentaro FujiwaraYoichi NishiiTakeo InoueOsamu HatajiMasamichi Mineshita

Published in: Thoracic cancer (2021)

Cisplatin plus pemetrexed regimen may be a preferable option to consider for subsequent consolidation therapy with durvalumab in patients with unresectable stage III adenocarcinoma.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
small cell lung cancer
advanced non small cell lung cancer
idiopathic pulmonary fibrosis
smoking cessation
epidermal growth factor receptor